Patents Assigned to Anergen, Inc. a wholly-owned subsidiary of Corixa Corporation
  • MHC conjugates useful in ameliorating autoimmunity
    Publication number: 20030068363
    Abstract: The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.
    Type: Application
    Filed: July 19, 2002
    Publication date: April 10, 2003
    Applicant: Anergen, Inc. a wholly-owned subsidiary of Corixa Corporation
    Inventors: Brian R. Clark, Somesh D. Sharma, Bernard L. Lerch